Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

The myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

Sensodyne, a leading oral care brand from Haleon (formerly GlaxoSmithKline Consumer Healthcare), sets a GUINNESS WORLD RECORD™ for successfully attempting the 'Most online dental screening tests ...

Learn more about whether Exact Sciences Corporation or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ ...

Manchester-based HIV charity George House Trust has won a GSK Impact Award – one of the nation’s top healthcare charity ...

GlaxoSmithKline has found a replacement for ... His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK ...